Patents
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
08/2001
08/15/2001CN1308062A 1-substituted-N-sulfinyl-2-aziridine methylenimine and its preparation and use
08/14/2001US6274762 Iodination a 5-aminobenzoic acid or 5-aminobenzamide in aqueous solution
08/14/2001CA2159640C Second messenger cell signaling inhibitors
08/09/2001WO2001056972A1 Method for synthesis of n-[(s)-1-carboxybutyl]-(s)-alanine esters and use in synthesis of perindopril
08/09/2001WO2001056956A1 A process for the crystallization of non-sucrose substances
08/09/2001WO2001056560A1 Substituted amino acids as neutral sphingomyelinase inhibitors
08/09/2001WO2001056353A2 Novel method for synthesis of n-[(s)-1-carboxybutyl]-(s)-alanine esters and use in synthesis of perindopril
08/09/2001WO2001032596A8 Phenoxy carboxylic acid compounds and compositions for delivering active agents
08/09/2001US20010012857 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
08/09/2001CA2399792A1 Substituted amino acids as neutral sphingomyelinase inhibitors
08/08/2001EP1121351A2 Preparation of (s)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes
08/08/2001CN1307558A Process for the preparation of 4-carboxy-5,8,11-tris (carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridencan-13-oic acid
08/08/2001CN1069308C Process for purifying valine
08/07/2001US6271258 Process for the preparation of stable, non-hygroscopic salts of L(-)carnitine
08/02/2001WO2001055091A1 Solid-supported process for making n-substituted peptide mimetic compounds
08/02/2001WO2001055090A1 Asymmetric synthesis of pregabalin
08/02/2001WO2000066564A8 Benzimidazolones and analogues and their use as progesterone receptor ligands
08/02/2001US20010011074 Antiischemic agents; cardiovascular disorders
08/01/2001CN1306505A Substituted benzamides, their prodn. and use
08/01/2001CN1306502A Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate
08/01/2001CN1305992A Method for preparing aryl alkyl hydrogen peroxide
08/01/2001CN1305991A Method for preparing aryl alkyl hydrogen peroxide
08/01/2001CN1305987A Process for preparing dialkylamino ethanol carboxylate and its salt
07/2001
07/31/2001US6268507 Hydantoin derivatives
07/31/2001US6268387 Inhibitors of the enzyme 15-lipoxygenase and are inhibitors of monocyte chemotaxis.
07/31/2001US6268207 Resolution of enantiomers from a mixture of (1r,2s)/(1s,2s)-1-amino-2-vinylcyclopropyl carboxylic acid methyl ester comprising the step of treating said mixture with an esterase to obtain the corresponding (1r,2s) enantiomer
07/26/2001WO2001053251A1 Process for producing 3-nitro-2-(mono-substituted)aminobenzoic acid ester
07/26/2001WO2001053240A1 Method for producing carboxylic acids by alcohol oxidation
07/26/2001WO2001052900A2 Novel orthogonally protected amino acid chelators for biomedical applications
07/26/2001WO1999015129A3 SELECTIVE cPLA2 INHIBITORS
07/26/2001US20010009923 Salt with pamoic acid, used in treatment of myocardial ischemia, angina pectoris, heart failure and arrhythmias; muscular asthenia and cramps; as food supplement, dietetic
07/25/2001EP1118608A1 Aminopolycarboxylates, process for producing the same and use thereof
07/25/2001EP1117633A1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use
07/25/2001EP0862464A4 Amino acid analogs for tumor imaging
07/24/2001US6265605 Additive in processed meat, beverages, and in other processed food stuffs; as intermediates in drugs, agricultural chemicals and pesticides, herbicides
07/24/2001US6265587 Intermediary compounds for the hemisynthesis of taxanes and preparation processes therefor
07/24/2001US6265433 LTA4 hydrolase inhibitors
07/24/2001US6264790 Process for the peracid bleaching of chelated chemical pulp
07/24/2001US6264411 Locking nut bolt and clip systems and assemblies
07/19/2001WO2001051919A2 High-throughput formation, identification, and analysis of diverse solid-forms
07/19/2001WO2001051487A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
07/19/2001WO2001051474A2 Polypharmacophoric agents
07/19/2001US20010008948 Preparing salts of aliphatic carboxylic acid compound via contacting primary alcohol with a catalyst in alkaline medium; animal feeds
07/19/2001US20010008947 Administering derivative of 2-amino-4-phenyl-4-oxo-butyric acid which acts as kynureninase/kynurenine-3-hydroxylase enzyme inhibitor; neurodegenerative diseases
07/19/2001US20010008946 Therapeutic nucleosides
07/19/2001US20010008945 Reducing 2-amido-1,3-malonic diester derivative to form 2-amino-1,3-malonic acid derivative
07/19/2001US20010008943 Starting materials for fungicides of lipopeptide type; isomer/impurity free
07/19/2001CA2396087A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
07/19/2001CA2396079A1 High-throughput formation, identification, and analysis of diverse solid-forms
07/18/2001EP1116712A1 Amine derivatives and skin preparations for external use containing the same
07/18/2001EP1116711A2 2-aminoalkyl-1,4-diaminobenzene derivatives and dye composition containing these compounds
07/18/2001EP1115696A1 Method for producing (-)-alpha-(difluoromethyl)ornithine-monohydrochloride monohydrate
07/18/2001EP1115695A1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
07/18/2001EP1115694A1 Substituted n-aliphatic-n-aromatic (tertiary)-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
07/18/2001EP1115693A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
07/18/2001EP1115481A1 Compound storage
07/17/2001US6262299 Zwitterionic monomer having amino-multicarboxylic acid functionality
07/17/2001US6262120 GABA and L-glutamic acid analogs for antiseizure treatment
07/17/2001US6261776 Nucleic acid arrays
07/12/2001WO2001049654A2 Substituted aminomethyl-phenyl-cyclohexane derivatives
07/12/2001WO2001049653A1 Process for preparing alkylene diamine triacetic acid
07/12/2001DE19963179A1 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases
07/12/2001DE10000312A1 Substituierte Aminomethyl-Phenyl-Cyclohexanderivate Substituted aminomethyl-phenyl-cyclohexane derivatives
07/12/2001CA2396304A1 Substituted aminomethyl-phenyl-cyclohexane derivatives
07/11/2001EP1114023A1 Process for preparing carboxylic acids
07/11/2001EP0821679B1 Asymmetric epoxides, their synthesis and use
07/10/2001US6258982 Process for the preparation of substituted aromatic amino compounds
07/10/2001US6258956 Reactinga oxoester with a benzene compound
07/10/2001US6258931 Synthesizing deoxyhypusine derivative by using ester of diprotected lysine, deblocking one nitrogen, condensing with 3-cyanopropanal, reducing to a triamine, protecting free amino groups, deblocking again, and acylating the free amino group
07/10/2001US6258854 Ketone ethers for odors
07/10/2001US6258572 Process for preparing L-aspartic acid
07/10/2001US6258161 Containing betaine as an air entraining agent, which may be used in combination with efflorescence control admixtures
07/05/2001WO2001048175A2 METHODS FOR PRODUCING ENANTIOMERICALLY PURE α-SUBSTITUTED CARBOXYLIC ACIDS
07/05/2001WO2001047908A1 Stereospecific hydrolysis of optically active esters
07/05/2001WO2001047892A1 Tricyclic protein kinase inhibitors
07/05/2001WO2001047867A1 Squaric acid derivatives as integrin antagonists
07/05/2001WO2001047866A1 Substituted 1 and 2 naphthol mannich bases
07/05/2001WO2001047859A1 Compounds active at the glucocorticoid receptor
07/05/2001WO2000050376A3 Efficient synthesis of alkyl carbonates
07/05/2001US20010007042 Process for preparing alkylene diamine triacetic acid
07/05/2001US20010006962 Behavior of biologically active compounds favorably modified by replacing a functional group with an unsaturated fatty derivative, e.g. elaidic acid; bioavailability; membrane passage; organ targeting; drugs; agriculture
07/05/2001CA2396579A1 Tricyclic protein kinase inhibitors
07/05/2001CA2394098A1 Substituted 1 and 2 naphthol mannich bases
07/05/2001CA2393583A1 Compounds active at the glucocorticoid receptor
07/05/2001CA2365224A1 Methods for producing enantiomerically pure .alpha.-substituted carboxylic acids
07/04/2001EP1112288A1 Thermal- and photoinitiated radical polymerization in the presence of an addition fragmentation agent
07/04/2001EP0828522B1 Polymer, article and method for inhibiting the growth of ocular pathogens in eye care products
07/04/2001EP0748326B1 Optically active diphosphines and method for preparing same by resolution of the racemic mixture
07/04/2001CN1302287A Bioreductive cytotoxic agents
07/03/2001US6255526 Reacting solution of gabapentin hydrochloride with additional amine in a first solvent to produce polymorphic precipitate form, then recovering converted form from methanol slurry and/or crystallization; treatment of cerebral diseases
07/03/2001US6255503 Water-soluble salts of dodecandioic acid and pharmaceutical and nutritional compositions containing same
07/03/2001US6255496 Trifluoromethyl ketone analogs as selective cPLA2 inhibitors
07/03/2001US6255345 GABA and L-glutamic acid analogs for antiseizure treatment
07/03/2001US6254850 Polycarboxyalkylaminoalkanes for complexes
07/03/2001US6254651 Reaction products of long chain esters with amines improve the cold flow properties
06/2001
06/28/2001WO2001046207A1 Chelating compounds, their complexes with paramagnetic metals
06/28/2001WO2001046137A1 Farnesyl transferase inhibitors
06/28/2001WO2001046114A1 Method for making hbed
06/28/2001WO2001045696A1 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid in iron chelating therapy
06/28/2001WO2000076662A3 Microenabled chemical reaction in microfluidic chips